Trabectedin
Trabectedin has been studied in 1 paper since 2024: 1 observational study in people. The newest paper, Jan 28, 2024: “Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)”.